PWP
AVNS

Personal Wealth Partners’s Avanos Medical AVNS Stock Holding History

Personal Wealth Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3
Closed – – 512
2019
Q3 		$0 Buy
+3
New +$114 ﹤0.01% 524

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Personal Wealth Partners's AVNS Position: Q4 2019 in Review

Personal Wealth Partners sold out of Avanos Medical (AVNS) in Q4 2019, closing a stake of 3 shares.

Personal Wealth Partners first reported a position in AVNS in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 293 funds tracked by Wall St. Rank hold AVNS as of Q4 2019.

  • Personal Wealth Partners reported no remaining Avanos Medical position as of Q4 2019 after selling out during the quarter.
  • Personal Wealth Partners sold 3 Avanos Medical shares in Q4 2019.
  • Personal Wealth Partners first reported a position in Avanos Medical in Q3 2019 and held it in 1 quarter.
  • Personal Wealth Partners's Avanos Medical position peaked at $0 in Q3 2019.
  • 293 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2019.

Based on Personal Wealth Partners's 13F filing for Q4 2019, filed 28 Jan 2020.